# Editorial: Machine learning advancements in pharmacology: transforming drug discovery and healthcare

**Authors:** Moom Rahman Roosan, Ramgopal Mettu

PMC · DOI: 10.3389/fphar.2025.1583486 · Frontiers in Pharmacology · 2025-03-07

## Full-text entities

- **Diseases:** nasopharyngeal carcinoma (MESH:D000077274), angioimmunoblastic T-cell lymphoma (MESH:D016399), Inflammation (MESH:D007249), ML (MESH:D007859), cancer (MESH:D009369)
- **Chemicals:** dopaminergic (MESH:D004298), SCH23390 (MESH:C534628), Triglyceride (MESH:D014280), amphetamine (MESH:D000661), chidamide (MESH:C547816), raclopride (MESH:D020891), lipid (MESH:D008055), dopaminergic compounds (-), clozapine (MESH:D003024)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11926139/full.md

---
Source: https://tomesphere.com/paper/PMC11926139